$
Federal Contract Award
Glaxosmithkline, LLC
Department of Health and Human Services · September 26, 2025 · FY2025
75A50325C00019Full & OpenNAICS 325412
Obligated
$9,099,990
Contract details
- Award ID
- CONT_AWD_75A50325C00019_7505_-NONE-_-NONE-
- PIID
- 75A50325C00019
- Period of performance
- September 30, 2025 → September 29, 2026
- Place of performance
- DURHAM, NC, USA
- Set-aside
- None (Full & Open)
- Pricing type
- FIRM FIXED PRICE
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- NAICS
- 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
Scope
RELENZA (ZANAMIVIR) ROTADISK, 5MG
Parent vehicle (IDV)
Glaxosmithkline, LLC
UEI FRHTPHMZMX47
This award was placed as a task/delivery order under a larger contract vehicle.
Awarding agency
Department of Health and Human Services →- Sub-agency
- Office of Assistant Secretary for Preparedness and Response
- Office
- ASPR/ORM-SNS
- Funding agency
- Department of Health and Human Services
- Funding office
- ASPR/ORM-SNS
See every contract Glaxosmithkline, LLC has won
Full contracting history, year-over-year trends, subaward graph, and recompete alerts.
View Glaxosmithkline, LLC profile →